Regeneron Pharmaceuticals: Q3 Earnings Insights

Regeneron Pharmaceuticals REGN reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Regeneron Pharmaceuticals beat estimated earnings by 17.02%, reporting an EPS of $11.14 versus an estimate of $9.52.

Revenue was down $517.00 million from the same period last year.

Last quarter the company beat on EPS by $0.23 which was followed by a 1.02% increase in the share price the next day.

Here's a look at Regeneron Pharmaceuticals's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	9.54	10.04	18.11	9.49
EPS Actual	9.77	11.49	23.72	15.37
Revenue Estimate	2.79B	2.73B	4.47B	2.79B
Revenue Actual	2.86B	2.96B	4.95B	3.45B

To track all earnings releases for Regeneron Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar